<DOC>
	<DOCNO>NCT02718599</DOCNO>
	<brief_summary>To evaluate effect terlipressin infusion systemic hepatic hemodynamics hepatobiliary surgery</brief_summary>
	<brief_title>Effect Terlipressin Infusion Systemic Hepatic Hemodynamics During Hepatobiliary Surgery</brief_title>
	<detailed_description />
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>Age &gt; 18 year . Any gender . ASA ( American Society Anesthesiologists ) Classification ( Class III ) Patients undergo elective hepatobiliary surgery . Benign malignant disease . Written inform consent Preoperative renal failure ( GFR &lt; 50 ml/min ) . Severe liver dysfunction ( Child turcot Pugh grade C ) . Hyponatremia ( &lt; 132 mmol/l ) . Severe aortic regurgitation , severe mitral regurgitation , heart failure . Symptomatic coronary heart disease . Bradycardic arrhythmia ( heart rate &lt; 60/min ) . Peripheral artery occlusive disease ( clinical stadium IIIV ) . Uncontrolled arterial hypertension ( Blood pressure &gt; 160/100 mmHg despite intensive treatment ) . Present suspect acute mesenteric ischemia . Septic shock low cardiac output . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>